Articles de revues sur le sujet « Pharmaceutical biotechnology – Law and legislation »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Pharmaceutical biotechnology – Law and legislation ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Omelchenko, Olha. "Some aspects of the intellectual property legislation development to expand access to biotechnology medicines." Theory and Practice of Intellectual Property, no. 1 (March 18, 2025): 97–104. https://doi.org/10.33731/12025.325004.
Texte intégralDel CASTILLO Rodríguez, Carlos. "PHARMACEUTICAL LEGISLATION OR PHARMACEUTICAL LAW? ANALYSIS." Vitae 18, no. 1 (2011): 83–87. http://dx.doi.org/10.17533/udea.vitae.8771.
Texte intégralIvanenko, Dmytro, and Nataliia Hlushchenko. "LEGAL ASPECTS OF INTELLECTUAL PROPERTY IMPACT ON AVAILABILITY OF MEDICINES IN UKRAINE." Law Journal of Donbass 76, no. 3 (2021): 39–44. http://dx.doi.org/10.32366/2523-4269-2021-76-3-39-44.
Texte intégralOmelchenko, Olha. "Intellectual property rights in the context of biology, medicine and pharmacy: a look into the future." Theory and Practice of Intellectual Property, no. 3 (June 19, 2023): 109–17. http://dx.doi.org/10.33731/32023.282330.
Texte intégralHolman, Christopher M. "Congress Considering Legislation Aimed at Increasing Competition in Pharmaceuticals." Biotechnology Law Report 38, no. 3 (2019): 144–53. http://dx.doi.org/10.1089/blr.2019.29125.cmh.
Texte intégralAlbolino, Sara, Tommaso Bellandi, Simone Cappelletti, et al. "New Rules on Patient’s Safety and Professional Liability for the Italian Health Service." Current Pharmaceutical Biotechnology 20, no. 8 (2019): 615–24. http://dx.doi.org/10.2174/1389201020666190408094016.
Texte intégralSEREBRENNIKOVA, ANNA. "PHARMACEUTICAL LAW: CRIMINAL ASPECTS." Gaps in Russian Legislation 14, no. 6 (2021): 203–9. http://dx.doi.org/10.33693/2072-3164-2021-14-6-203-209.
Texte intégralFrolova, O. "Implementation of EU legislation into the criminal legislation of Ukraine to ensure criminal legal protection of pharmaceutical activity." Scientific and informational bulletin of Ivano-Frankivsk University of Law named after King Danylo Halytskyi, no. 16(28) (December 13, 2023): 176–83. http://dx.doi.org/10.33098/2078-6670.2023.16.28.176-183.
Texte intégralMalinowski, Michael J. "Pharmaceutical Medicine, Biotechnology and European Law." Journal of Legal Medicine 23, no. 1 (2002): 159–66. http://dx.doi.org/10.1080/019476402317276722.
Texte intégralNoguera Peña, Alfonso, and Carlos del Castillo Rodríguez. "Pharmaceutical Law and Pharmaceutical Legislation in Spain and in the European Union: Concept, Evolution and Sources." Anales de la Real Academia Nacional de Farmacia 87, no. 87(03) (2021): 275–322. http://dx.doi.org/10.53519/analesranf.2021.87.03.06.
Texte intégralFrolova, O. G. "Criminal legal protection of pharmaceutical activity on the circulation of medicinal products in acts of foreign criminal legislation." Analytical and Comparative Jurisprudence, no. 5 (November 17, 2023): 495–501. http://dx.doi.org/10.24144/2788-6018.2023.05.89.
Texte intégralYurkovska, Lidiia H., Volodymyr V. Krasnov, and Serhii H. Ubohov. "QUALITY ASSURANCE OF MEDICINES: THE STATE AND TRENDS OF THE EUROPEAN UNION AND UKRAINE LEGISLATION DEVELOPMENT." Wiadomości Lekarskie 74, no. 1 (2021): 150–54. http://dx.doi.org/10.36740/wlek202101129.
Texte intégralAleksieiev, O. H. "Grounds for legal liability in the pharmaceutical sector of the healthcare sector." Zaporozhye Medical Journal 23, no. 2 (2021): 280–85. http://dx.doi.org/10.14739/2310-1210.2021.2.228794.
Texte intégralvan Wyk, Christa. "Book Review: Pharmaceutical Medicine, Biotechnology, and European Law." Maastricht Journal of European and Comparative Law 8, no. 4 (2001): 397–405. http://dx.doi.org/10.1177/1023263x0100800404.
Texte intégralHarris, Rebecca C. "State responses to biotechnology." Politics and the Life Sciences 34, no. 1 (2015): 1–27. http://dx.doi.org/10.1017/pls.2015.2.
Texte intégralBrosch, Sabine, and Alessandro Spina. "International Conference on Harmonisation and Standardisation Initiatives in the Pharmaceutical Domain." European Journal of Risk Regulation 1, no. 3 (2010): 274–76. http://dx.doi.org/10.1017/s1867299x00000477.
Texte intégralFirman Erry Probo, Anis Widyawati, and Duhita Driyah Suprapti. "CRIMINAL LAW POLICY OF ILLEGAL PHARMACEUTICAL PREPARATIONS IN THE HEALTH OMNIBUS LAW." MORFAI JOURNAL 4, no. 4 (2025): 1566–71. https://doi.org/10.54443/morfai.v4i4.2428.
Texte intégralDrigo, A. E., L. I. Lavrenteva, O. V. Zheltkevich, and N. V. Korchkova. "Topical issues of pharmaceutical organization systematization." Remedium Journal about the Russian market of medicines and medical equipment, no. 11-12 (2020): 55–60. http://dx.doi.org/10.21518/1561-5936-2020-11-12-55-60.
Texte intégralVarela, Justo Corti. "Biotechnology." European Journal of Risk Regulation 1, no. 1 (2010): 63–71. http://dx.doi.org/10.1017/s1867299x00000076.
Texte intégralLentz, Edward T. "Pharmaceutical and Biotechnology Research Revisited." Biotechnology Law Report 25, no. 1 (2006): 2–5. http://dx.doi.org/10.1089/blr.2006.25.2.
Texte intégralFrolova, Olena. "CAUSING HARM TO PHARMACEUTICAL ACTIVITY AS AN OBJECT OF CRIMINAL LAW PROTECTION." Scientific Journal of Polonia University 62, no. 1 (2024): 151–57. http://dx.doi.org/10.23856/6220.
Texte intégralMorozova, Natalya Arkadyevna. "Issues of interaction and cooperation between prescribers and pharmaceutical companies." Ophthalmology journal 6, no. 3 (2013): 4–8. http://dx.doi.org/10.17816/ov201334-8.
Texte intégralAleksieiev, O. H. "Conceptual and category apparatus of legislation, what determines legal responsibility in pharmaceutical activity." Current issues in pharmacy and medicine: science and practice 15, no. 2 (2022): 201–7. http://dx.doi.org/10.14739/2409-2932.2022.2.255817.
Texte intégralOlzhabayeva, X. B. "Analysis of Kazakhstan legislation regulating the labour of medical and pharmaceutical workers." BULLETIN of L.N. Gumilyov Eurasian National University. Law Series 137, no. 4 (2021): 132–41. http://dx.doi.org/10.32523/2616-6844-2021-137-4-132-141.
Texte intégralGuţiu, Simona. "Some considerations of Romanian legal framework on online sale of OTC medicine. Coordination or contradiction to European legislation?" Proceedings of the International Conference on Business Excellence 15, no. 1 (2021): 930–35. http://dx.doi.org/10.2478/picbe-2021-0086.
Texte intégralPashkov, V. M. "LEGAL REGULATION OF MOST DANGEROUS MICROORGANISMS STRAINS HANDLING." Medicne pravo, no. 2(28) (October 7, 2021): 71–79. http://dx.doi.org/10.25040/medicallaw2021.02.071.
Texte intégralSpina, Alessandro. "Pharmaceuticals." European Journal of Risk Regulation 1, no. 1 (2010): 81–82. http://dx.doi.org/10.1017/s1867299x00000106.
Texte intégralJablonski, Tomasz. "End of the Transitional Period for Traditional Herbal Medicinal Products Coming Soon." European Journal of Risk Regulation 1, no. 2 (2010): 156–59. http://dx.doi.org/10.1017/s1867299x0000026x.
Texte intégralBombillar, Francisco. "The Case of Pandemic Flu Vaccines: Some Lessons Learned." European Journal of Risk Regulation 1, no. 4 (2010): 427–31. http://dx.doi.org/10.1017/s1867299x00000908.
Texte intégralKiedrzynek, Michał. "Ewolucja administracji farmaceutycznej w Polsce." Studenckie Prace Prawnicze, Administratywistyczne i Ekonomiczne 20 (September 20, 2017): 65–76. http://dx.doi.org/10.19195/1733-5779.20.5.
Texte intégralKondrat'ev, V. A. "Consumerism Qualification: Doctrine and Case Law." Rossijskoe pravosudie 5 (May 25, 2021): 22–28. http://dx.doi.org/10.37399/issn2072-909x.2021.5.22-28.
Texte intégralPirtskhalava, Kh D. "Ethical Standards in Innovative Medicine." Courier of Kutafin Moscow State Law University (MSAL)), no. 9 (December 21, 2023): 182–87. http://dx.doi.org/10.17803/2311-5998.2023.109.9.182-187.
Texte intégralFaltus, Timo. "The Medicinal Phage—Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation." Viruses 16, no. 3 (2024): 443. http://dx.doi.org/10.3390/v16030443.
Texte intégralZhang, Jing, Shuchen Tang, and Pengqing Sun. "From Command-Control to Lifecycle Regulation: Balancing Innovation and Safety in China’s Pharmaceutical Legislation." Healthcare 13, no. 6 (2025): 588. https://doi.org/10.3390/healthcare13060588.
Texte intégralShapovalov, Valerii. "Судова фармація, організація фармацевтичної справи, технологія ліків, медичне, фармацевтичне та кримінальне право: державна система боротьби із незаконним обігом наркотичних засобів і психотропних речовин та зловживання ними в умовах пандемії". SSP Modern Law and Practice 2, № 3 (2022): 1–35. http://dx.doi.org/10.53933/sspmlp.v2i3.66.
Texte intégralSdvizhkov, M. А. "Antitrust Compliance in the Pharmaceutical Industry: Problems and Prospects of Implementation." Russian competition law and economy, no. 4 (January 12, 2022): 52–59. http://dx.doi.org/10.47361/2542-0259-2021-4-28-52-59.
Texte intégralManak, Joseph M. "The Law of Written Description in Pharmaceutical and Biotechnology Patents." Biotechnology Law Report 23, no. 1 (2004): 30–47. http://dx.doi.org/10.1089/073003104322838231.
Texte intégralKhassenov, M. K. "Some issues of labor regulation of medical and pharmaceutical workers in selected OECD countries." BULLETIN of L.N. Gumilyov Eurasian National University. Law Series 137, no. 4 (2021): 98–109. http://dx.doi.org/10.32523/2616-6844-2021-137-4-98-109.
Texte intégralMokhov, A. A. "The Concept of Four "Bio" in Law and Legislation." Actual Problems of Russian Law 15, no. 8 (2020): 146–54. http://dx.doi.org/10.17803/1994-1471.2020.117.8.146-154.
Texte intégralLisman, John A., and J. Frits F. Lekkerkerker. "Four decades of European medicines regulation: What have they brought us?" International Journal of Risk & Safety in Medicine 17, no. 1-2 (2005): 73–79. https://doi.org/10.3233/jrs-2005-337.
Texte intégralFernando, Andrian, and Tri Susilowati. "Legislative Functions of the House of Representatives in the Perspective of the 1945 Constitution of the Republic of Indonesia." Jurnal Indonesia Sosial Sains 4, no. 06 (2023): 523–30. http://dx.doi.org/10.59141/jiss.v4i06.828.
Texte intégralAleksieiev, O. H. "Conceptual and terminological apparatus for disciplinary responsibility in pharmaceutical activity." Current issues in pharmacy and medicine: science and practice 16, no. 2 (2023): 181–85. http://dx.doi.org/10.14739/2409-2932.2023.2.277085.
Texte intégralVakhonieva, T. "LEGAL STATUS AND QUALIFICATION REQUIREMENTS FOR PHARMACEUTICAL WORKERS." Bulletin of Taras Shevchenko National University of Kyiv. Legal Studies, no. 116 (2021): 11–14. http://dx.doi.org/10.17721/1728-2195/2021/1.116-2.
Texte intégralХабриева, Талия, and Taliya Khabriyeva. "Main Vectors and Problems of Development of Social Legislation." Journal of Russian Law 2, no. 8 (2014): 5–15. http://dx.doi.org/10.12737/5271.
Texte intégralPrepyalov, Alexander V. "A medicine as an object of civil rights: A concept, attributes and comparison to the foreign approach." Vestnik of Saint Petersburg University. Law 13, no. 4 (2022): 1058–77. http://dx.doi.org/10.21638/spbu14.2022.414.
Texte intégralKrasnianska, Tetiana, and Mykola Ponomarenko. "Organization of the Pharmaceutical Business, Drug Technology and Forensic Pharmacy: Modern Trends in The Development of the Science of Pharmaceutical Law During the Covid-19 Pandemic." SSP Modern Pharmacy and Medicine 2, no. 3 (2022): 1–15. http://dx.doi.org/10.53933/sspmpm.v2i3.59.
Texte intégralLiikanen, Erkki. "Changes to the European Union pharmaceutical legislation: Implications of the ‘Pharma Review’ for biotechnology companies." Journal of Commercial Biotechnology 11, no. 1 (2004): 38–43. http://dx.doi.org/10.1057/palgrave.jcb.3040099.
Texte intégralK. A., Krasnova. "Crime in Esports – Criminal Law Considerations." Rossijskoe pravosudie, no. 10 (September 27, 2021): 90–97. http://dx.doi.org/10.37399/issn2072-909x.2021.10.90-97.
Texte intégralBeletsky, Leo. "21st Century Cures for the Opioid Crisis: Promise, Impact, and Missed Opportunities." American Journal of Law & Medicine 44, no. 2-3 (2018): 359–85. http://dx.doi.org/10.1177/0098858818789417.
Texte intégralBerzin, P., R. Volynets, and O. Frolova. "Atypical features of the Austrian model of criminal law protection of circulation of medical devices." Uzhhorod National University Herald. Series: Law 2, no. 80 (2024): 16–22. http://dx.doi.org/10.24144/2307-3322.2023.80.2.2.
Texte intégral